Informa plc (LON:INF - Get Free Report) has received a consensus rating of "Buy" from the six analysts that are currently covering the stock, Marketbeat.com reports. Six research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have covered the stock in the last year is GBX 1,160.
Several analysts have recently issued reports on INF shares. JPMorgan Chase & Co. decreased their price objective on Informa from GBX 1,300 to GBX 1,285 and set an "overweight" rating on the stock in a report on Thursday, July 2nd. Berenberg Bank reissued a "buy" rating and issued a GBX 1,040 target price on shares of Informa in a report on Thursday, October 8th. Citigroup boosted their price target on shares of Informa from GBX 990 to GBX 1,090 and gave the stock a "buy" rating in a research report on Wednesday, August 12th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of Informa from GBX 1,140 to GBX 1,290 and gave the stock a "buy" rating in a research report on Friday, October 9th.
View Our Latest Stock Analysis on Informa
Informa Price Performance
Shares of Informa stock opened at GBX 890.80 on Wednesday. The stock has a 50 day moving average of GBX 892.37 and a 200 day moving average of GBX 855.42. Informa has a 12 month low of GBX 719 and a 12 month high of GBX 1,000. The firm has a market cap of £11.13 billion, a PE ratio of 52.09, a PEG ratio of 0.75 and a beta of 0.71. The company has a current ratio of 0.55, a quick ratio of 1.70 and a debt-to-equity ratio of 64.99.
Informa (LON:INF - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported GBX 26.70 earnings per share for the quarter. Informa had a return on equity of 3.90% and a net margin of 5.43%. On average, research analysts expect that Informa will post 59.32 EPS for the current fiscal year.
Informa Company Profile
(
Get Free Report)
Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.
We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.
And we do this through a range of products and services, including major live events, specialist media and content, expert research articles, books and open research platforms, accredited training, buyer discovery services, and digital demand and lead-generation services.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Informa, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Informa wasn't on the list.
While Informa currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.